Innate Pharma SA's total assets for Q4 2024 were €111.06M, a decrease of -26.69% from the previous quarter. FR:IPH total liabilities were €102.22M for the fiscal quarter, a -16.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.